» Articles » PMID: 39648639

Research Progress on the Pathogenesis of Multiple Symmetrical Lipomatosis

Overview
Journal Adipocyte
Date 2024 Dec 9
PMID 39648639
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple symmetric lipomatosis, also known as madelung's disease, is a rare syndrome characterized by the accumulation of multiple symmetric subcutaneous adipose tissues that significantly affect patients' quality of life. Since the aetiology of the disease is still unclear, surgical intervention by doctors based on clinical experience is currently the main treatment. However, the recurrence rate remains high even after surgical intervention. Therefore, studying the pathogenesis of this disease is particularly important for overcoming this challenge. In this paper, we reviewed and summarized recent research results on the pathogenesis of this disease to provide possible research directions and treatment strategies for this disease, but no clear mechanism was identified.'Level of Evidence: Level I, Review Articles'.

References
1.
Tapscott S, Weintraub H . MyoD and the regulation of myogenesis by helix-loop-helix proteins. J Clin Invest. 1991; 87(4):1133-8. PMC: 295115. DOI: 10.1172/JCI115109. View

2.
Sollier C, Capel E, Aguilhon C, Smirnov V, Auclair M, Douillard C . LIPE-related lipodystrophic syndrome: clinical features and disease modeling using adipose stem cells. Eur J Endocrinol. 2020; 184(1):155-168. DOI: 10.1530/EJE-20-1013. View

3.
Nerlich A, Perciaccante A, Donell S, Bianucci R . Madelung's disease in a rare 14th century Franco-Flemish woolen tapestry. Lancet Diabetes Endocrinol. 2022; 10(9):619-620. DOI: 10.1016/S2213-8587(22)00213-3. View

4.
Vassallo G, Mirijello A, Tarli C, Rando M, Antonelli M, Garcovich M . Madelung's disease and acute alcoholic hepatitis: case report and review of literature. Eur Rev Med Pharmacol Sci. 2019; 23(14):6272-6276. DOI: 10.26355/eurrev_201907_18448. View

5.
Chen K, Wan X, Zhao L, Zhao S, Peng L, Yang W . Cbl Proto-Oncogene B (CBLB) c.197A>T Mutation Induces Mild Metabolic Dysfunction in Partial Type I Multiple Symmetric Lipomatosis (MSL). Diabetes Metab Syndr Obes. 2020; 13:3535-3549. PMC: 7547790. DOI: 10.2147/DMSO.S273780. View